FTLF

Rating neutralAI Memo

FitLife Brands

As of 2026-09-06/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-09-06 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Irwin acquisition growth requires sustained sell-through • 2026-12-05

Base target: $10 / p=55% prob

Biggest risk

Consolidated growth remains acquisition-led while Legacy FitLife is contracting and gross margins are diluted; leverage and execution risks remain material.

Invalidation

Break below $7 or thesis failure.

What would change my mind?

Irwin-driven wholesale and online growth, sequential revenue stability, and ongoing debt paydown could improve earnings quality and support a rerating.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-09-06

Base target

$10

p=55%

Bull target

$14

p=20%

Bear target

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Legacy FitLife weakness remains the key downside monitor
Debt reduction and margin normalization could support rerating
Irwin-driven wholesale and online growth, sequential revenue stability, and ongoing debt paydown could improve earnings quality and support a rerating.

BearKey bullets

Analyst revisions, options positioning, social data, and post-release price-reaction attribution are unavailable.
Irwin's lower gross margin weighs on consolidated profitability.
Legacy FitLife revenue and contribution remain below prior-year levels.

WatchKey bullets

Irwin acquisition growth requires sustained sell-through

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Base case: $10 (p=55%)

Target spread vs base: +32% / -29%

Scenario probabilities

Bull Target: $14 (p=20%)Base Target: $10 (p=55%)Bear Target: $7 (p=25%)

Commentary

Recent coverage is concentrated around the Q2 2026 earnings release and is directionally constructive on consolidated growth, but coverage remains thin. Social sentiment, options skew, short interest, employee sentiment, analyst revisions, and post-release reaction attribution are unavailable. The evidence supports cautious monitoring rather than a high-conviction directional view.

As of 2026-09-06 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Irwin-driven wholesale and online growth, sequential revenue stability, and ongoing debt paydown could improve earnings quality and support a rerating.

Bear Case

Consolidated growth remains acquisition-led while Legacy FitLife is contracting and gross margins are diluted; leverage and execution risks remain material.

Drivers

Scannable catalysts and supporting factors

Legacy FitLife weakness remains the key downside monitor
Debt reduction and margin normalization could support rerating

Scenarios

Bull Target (Scenario probability)

$14 / p=20% prob

Base Target (Scenario probability)

$10 / p=55% prob

Bear Target (Scenario probability)

$7 / p=25% prob

Analysis 2026-09-06 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.20

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-05
Irwin acquisition growth requires sustained sell-through
Irwin contributed materially to Q2 revenue growth, while total revenue increased 4.8% sequentially. Continued wholesale and online traction would support the growth thesis; deceleration would highlight acquisition dependence [#SEC-8K-2026-08-13].
Prob 60.00% • Move 8.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

Legacy FitLife weakness remains the key downside monitor
2026-12-05
Q2 2026 Legacy FitLife revenue fell 23% year over year, while consolidated gross margin declined to 37.0% from 42.8%, primarily due to Irwin's lower-margin mix. A further deterioration could pressure earnings and sentiment [#SEC-8K-2026-08-13].
Prob 70% • Move -8% • Priced-in 65%

Long-term Catalysts

Months to a year

Debt reduction and margin normalization could support rerating
2027-09-06
The company reported $37.0 million of total net debt and approximately $8.6 million of debt repayment since acquiring Irwin. Continued cash-flow debt reduction and improved acquired-brand margins are prerequisites for a durable rerating [#SEC-8K-2026-08-13].
Prob 45% • Move 18% • Priced-in 20%

Risks

Analyst revisions, options positioning, social data, and post-release price-reaction attribution are unavailable.
Irwin's lower gross margin weighs on consolidated profitability.
Legacy FitLife revenue and contribution remain below prior-year levels.
Small-cap liquidity and low coverage may amplify volatility.
The business carries approximately $37.0 million of net debt against $1.1 million of cash.

Peers

Symbol	Summary
LFVN	Closest branded wellness and supplement comparator for channel mix, direct-to-consumer durability, and margin sensitivity.
MED	Larger consumer-health peer useful for demand elasticity, promotional pressure, and gross-margin risk framing.
UPXI	Looser small-cap wellness comparator, more relevant for balance-sheet and execution-risk framing than clean operating benchmarking.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-09-06

Loading AI feed…

Symbol

Summary

LFVN

Closest branded wellness and supplement comparator for channel mix, direct-to-consumer durability, and margin sensitivity.

MED

Larger consumer-health peer useful for demand elasticity, promotional pressure, and gross-margin risk framing.

UPXI

Looser small-cap wellness comparator, more relevant for balance-sheet and execution-risk framing than clean operating benchmarking.